# FDA Inspection 983208 - Tissue Banks International Inc - May 26, 2016

Source: https://www.keypedia.com/records/fda_inspections/tissue-banks-international-inc/8227e4f8-3388-4ad0-ba50-0d2b3eb0c316
Source feed: FDA_Inspections

> FDA Inspection 983208 for Tissue Banks International Inc on May 26, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 983208
- Company Name: Tissue Banks International Inc
- Inspection Date: 2016-05-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 786666 - 2012-05-11](https://www.keypedia.com/records/fda_inspections/tissue-banks-international-inc/6c8fcf79-7a03-4d32-8c6f-2c9162850ad8)
- [FDA Inspection 679602 - 2010-09-21](https://www.keypedia.com/records/fda_inspections/tissue-banks-international-inc/ace6dfbe-dcda-4dbe-88a7-1b905f0f9b10)

Company: https://www.keypedia.com/companies/tissue-banks-international-inc/3f95de90-063f-41e9-8904-53cdc4cd3867

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d